The key event in the initiation of The key event in the initiation of pharmacological responses is the formapharmacological responses is the formation of a complex between the ligand tion of a complex between the ligand (or drug or molecule) and its site of ac-(or drug or molecule) and its site of action (Taylor & Insel, 1990) . Competitive tion (Taylor & Insel, 1990) . Competitive binding experiments ascertain how specibinding experiments ascertain how specific the interaction is between a ligand fic the interaction is between a ligand and its binding site by examining the and its binding site by examining the ability of various compounds to compete ability of various compounds to compete with a radiolabelled reference probe for with a radiolabelled reference probe for the site. The more potently a drug binds the site. The more potently a drug binds to the receptor, the more effective it is at to the receptor, the more effective it is at competing for labelled sites. The greater competing for labelled sites. The greater the potency a drug has for the receptor, the potency a drug has for the receptor, the lower the concentration required the lower the concentration required before all available receptor sites are before all available receptor sites are occupied or blocked. This affinity occupied or blocked. This affinity (termed (termed K K d d or or K K i i ) for the receptor is ) for the receptor is quantified in test-tube experiments and quantified in test-tube experiments and is a function of the rate of drug associais a function of the rate of drug association and dissociation from the receptor. tion and dissociation from the receptor. It is empirically measured as the concenIt is empirically measured as the concentration of drug required to block half the tration of drug required to block half the total receptor population. High-affinity total receptor population. High-affinity drugs have low drugs have low K K d d values. These drugs values. These drugs are better at 'occupying' receptors. In livare better at 'occupying' receptors. In living animals, including humans, receptor ing animals, including humans, receptor occupancy by drugs is also determined occupancy by drugs is also determined by the rate of association and dissociaby the rate of association and dissociation of the drug from the receptors, the tion of the drug from the receptors, the concentration of drug at the receptor concentration of drug at the receptor and the concentration of endogenous and the concentration of endogenous neurotransmitter at the receptor (Strange, neurotransmitter at the receptor (Strange, 2001) . Rehearsing these dry pharmaco-2001) . Rehearsing these dry pharmacological concepts is important to our unlogical concepts is important to our understanding of antipsychotic drug action, derstanding of antipsychotic drug action, in particular how dopamine is the 'comein particular how dopamine is the 'comeback kid' for hypotheses of antipsychotic back kid' for hypotheses of antipsychotic drug action, a lead candidate for antidrug action, a lead candidate for antipsychotic drug discovery and relevant to psychotic drug discovery and relevant to the modern clinical management of the modern clinical management of schizophrenia. Here we shall discuss the schizophrenia. Here we shall discuss the dopamine hypothesis of drug action, redopamine hypothesis of drug action, review studies that have refined underview studies that have refined understanding of its relevance, and attempt to standing of its relevance, and attempt to synthesise the current view with respect synthesise the current view with respect to clinical management. to clinical management.
DOPAMINERGIC PATHWAYS DOPAMINERGIC PATHWAYS AND RECEPTOR PHYSIOLOGY AND RECEPTOR PHYSIOLOGY
Dopamine is one of the principal modulaDopamine is one of the principal modulatory neurotransmitters in the brain. Dopatory neurotransmitters in the brain. Dopamine systems arise from two primary mine systems arise from two primary midbrain clusters, the ventral tegmental midbrain clusters, the ventral tegmental area (A10) and the substantia nigra (A9), area (A10) and the substantia nigra (A9), which have discrete projections to mesowhich have discrete projections to meso- (D 2short 2short and D and D 2long 2long ), which are ), which are differentially localised in the brain. The differentially localised in the brain. The neurochemical anatomy of dopamine difneurochemical anatomy of dopamine differs in cortical and striatal regions, and it fers in cortical and striatal regions, and it now appears that dopamine concentration, now appears that dopamine concentration, receptor regulation and D receptor regulation and D 2 2 -like receptor -like receptor subtype density vary greatly between striasubtype density vary greatly between striatal and extrastriatal regions (Lidow tal and extrastriatal regions (Lidow et al et al, , 1998; Strange, 2001) . Antipsychotic drugs 1998; Strange, 2001) . Antipsychotic drugs are thought to achieve their main effects are thought to achieve their main effects (both beneficial and unwanted) by acting (both beneficial and unwanted) (Peroutka & Snyder, 1980) led to confirmation that it was a 1980) led to confirmation that it was a major site of action of antipsychotic drugs major site of action of antipsychotic drugs (Creese (Creese et al et al, 1976; Seeman , 1976; Seeman et al et al, 1976; , 1976; Johnstone Johnstone et al et al, 1978) . These findings , 1978). These findings rationalised clinical observation and pracrationalised clinical observation and practice at the time. Efforts to treat partially tice at the time. Efforts to treat partially or poorly responsive patients revolved or poorly responsive patients revolved around 'mega-dose' antipsychotic therapy, around 'mega-dose' antipsychotic therapy, although many contemporaneous papers although many contemporaneous papers questioned the usefulness of this approach questioned the usefulness of this approach (Baldessarini (Baldessarini et al et al, 1984; Van Putten & , 1984; Van Putten & Marder, 1986) . More D Marder, 1986 Chinks in the 'dopamine hypothesis' Chinks in the 'dopamine hypothesis' armour appeared with the clear demonarmour appeared with the clear demonstration that some patients taking therastration that some patients taking therapeutic doses of typical antipsychotic peutic doses of typical antipsychotic drugs not only failed to benefit from the drugs not only failed to benefit from the treatment, but also had levels of central treatment, but also had levels of central D D 2 2 receptor blockade in excess of 90% receptor blockade in excess of 90% (Wolkin (Wolkin et al et al, 1989; Pilowsky , 1989; Pilowsky et al et al, , 1993) . This finding obviated pharmaco-1993). This finding obviated pharmacokinetic explanations that poor clinical kinetic explanations that poor clinical effect was the result of low brain penetraeffect was the result of low brain penetration or increased wash-out of typical antition or increased wash-out of typical antipsychotic psychotic drugs in treatment-resistant drugs in treatment-resistant individuals. Indeed, some patients who reindividuals. Indeed, some patients who responded well to treatment showed remarksponded well to treatment showed remarkably low levels of D ably low levels of D 2 2 receptor blockade receptor blockade (Pilowsky (Pilowsky et al et al, 1993) . These data con-, 1993). These data contributed greatly to the consensus that tributed greatly to the consensus that high-dosage antipsychotic treatment was, high-dosage antipsychotic treatment was, 2 71 2 71 Other receptor systems were probed as Other receptor systems were probed as potential sites of antipsychotic drug action, potential sites of antipsychotic drug action, and a call was made to abandon preconand a call was made to abandon preconceived ideas of particular neurochemical ceived ideas of particular neurochemical profiles determining atypical drug activity profiles determining atypical drug activity until potential sites for drug discovery were until potential sites for drug discovery were better understood (Kerwin, 1994) . Simple better understood (Kerwin, 1994 receptor affinities was the major determireceptor affinities was the major determinant of a drug's likelihood to behave as nant of a drug's likelihood to behave as an atypical antipsychotic. Studies using an atypical antipsychotic. Studies using PET and SPET found that many atypical PET and SPET found that many atypical antipsychotic drugs, including clozapine, antipsychotic drugs, including clozapine, olanzapine, risperidone and quetiapine, olanzapine, risperidone and quetiapine, shared a strikingly high degree of 5-HT shared a strikingly high degree of 5-HT 2A
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receptor occupancy ( receptor occupancy (4 490%) over their en-90%) over their entire dose range (Nordstrom tire dose range (Nordstrom et al et al, 1993 (Nordstrom et al et al, , 1993a ; Nyberg Nyberg et al et al, 1993; Travis , 1993; Travis et al et al, 1998; , 1998; Kapur Kapur et al et al, 1999; Jones , 1999; Jones et al et al, 2001 ). This , 2001 ). This is unsurprising given that olanzapine, risis unsurprising given that olanzapine, risperidone and quetiapine were developed peridone and quetiapine were developed on the basis of their high 5-HT on the basis of their high 5-HT (2000) reported that in a group (2000) reported that in a group of patients receiving long-term typical of patients receiving long-term typical antipsychotic therapy, the women develantipsychotic therapy, the women developed symptomatic hyperprolactinaemia oped symptomatic hyperprolactinaemia at half the chlorpromazine equivalent dose at half the chlorpromazine equivalent dose of that in men (approximately 250 mg of that in men (approximately 250 mg chlorpromazine equivalents). chlorpromazine equivalents).
Dopamine transmission is Dopamine transmission is abnormal in schizophrenia abnormal in schizophrenia
Post-mortem studies of D Post-mortem studies of D 2 2 receptors in receptors in schizophrenia were crucial to the genesis schizophrenia were crucial to the genesis of the dopamine hypothesis. Increased of the dopamine hypothesis. Increased striatal D striatal D 2 2 receptor density was reported receptor density was reported by some authors (Lee & Seeman, 1980 ; by some authors (Lee & Seeman, 1980; Mackay Mackay et al et al, 1982) , but these findings , 1982), but these findings were questioned on the basis that the data were questioned on the basis that the data were obtained by studying antipsychoticwere obtained by studying antipsychotictreated patients. Classical antipsychotic treated patients. Classical antipsychotic therapy could, in itself, cause D therapy could, in itself, cause D 2 2 receptor receptor upregulation (Clow upregulation (Clow et al et al, 1980 ). Imaging , 1980 . Imaging studies using PET and SPET could control studies using PET and SPET could control for this confound by studying never-treated for this confound by studying never-treated people with schizophrenia. These studies people with schizophrenia. These studies did not, on the whole, support increased did not, on the whole, support increased striatal D striatal D 2 2 receptor density in schizophrenia receptor density in schizophrenia (Farde (Farde et al et al, 1990; Martinot , 1990; Martinot et al et al, 1990; , 1990; Pilowsky Pilowsky et al et al, 1994) , although the possibil-, 1994), although the possibility that endogenous dopamine concentraity that endogenous dopamine concentration was abnormal (Mackay tion was abnormal (Mackay et al et al, 1982; , 1982; Reynolds, 1983) 2 receptors by receptors by amphetamine-stimulated endogenous dopaamphetamine-stimulated endogenous dopamine release was approximately doubled in mine release was approximately doubled in the patient group compared with the conthe patient group compared with the control group. This effect was more striking trol group. This effect was more striking in the more acutely ill patients, although in the more acutely ill patients, although findings in many patients overlapped with findings in many patients overlapped with those in controls. These data, replicated those in controls. These data, replicated using a different PET technique (Breier using a different PET technique (Breier et al et al, 1997), provided concrete proof of dis-, 1997), provided concrete proof of disturbed dopamine control, at least in some turbed dopamine control, at least in some people with schizophrenia. Drawing on people with schizophrenia. Drawing on these and other data, Moore these and other data, Moore et al et al (1999) (1999) have thoughtfully argued that overactive have thoughtfully argued that overactive phasic dopamine transmission in limbic rephasic dopamine transmission in limbic regions (including the amygdala and nucleus gions (including the amygdala and nucleus accumbens) could account for misinterpreaccumbens) could account for misinterpretation of innocuous external stimuli (resulttation of innocuous external stimuli (resulting in delusions) and improper filtering ing in delusions) and improper filtering of perceptions (causing hallucinations). of perceptions (causing hallucinations). Blockade of D Blockade of D 2 2 receptors in these regions receptors in these regions would help control the positive symptoms would help control the positive symptoms of schizophrenia. In cortical (especially of schizophrenia. In cortical (especially frontal and prefrontal cortical) regions, frontal and prefrontal cortical) regions, these authors propose that tonic dopamine these authors propose that tonic dopamine transmission is relatively underactive, retransmission is relatively underactive, resulting in disrupted executive function, sulting in disrupted executive function, poverty of thought, speech and action, poverty of thought, speech and action, and low motivation. Antipsychotic occuand low motivation. Kapur & Seeman (2001) to conclude that owing to Seeman (2001) to conclude that owing to low affinity for the D low affinity for the D 2 2 receptor (driven, as receptor (driven, as these authors see it, by fast dissociation these authors see it, by fast dissociation 'off' the receptor) clozapine and quetiapine 'off' the receptor) clozapine and quetiapine exhibit transiently high D exhibit transiently high D 2 2 receptor occureceptor occupancy (not exceeding the threshold required pancy (not exceeding the threshold required to induce adverse movement or hormonal to induce adverse movement or hormonal side-effects), which declines to very low side-effects), which declines to very low levels over a 24 h period. This suggests that levels over a 24 h period. This suggests that low-affinity drugs, with modest effects at low-affinity drugs, with modest effects at D D 2 2 receptors, may antagonise the system receptors, may antagonise the system in a manner that preserves physiologically in a manner that preserves physiologically responsive endogenous dopamine transmisresponsive endogenous dopamine transmission across a wide dose range (Kapur sion across a wide dose range (Kapur et al et al, , 2000 (Kapur et al et al, , 2000b . The effect may presumably also be ). The effect may presumably also be achieved by higher-affinity drugs that are achieved by higher-affinity drugs that are cleared rapidly from the synapse, or given cleared rapidly from the synapse, or given at doses producing low synaptic concenat doses producing low synaptic concentrations of the drug (Strange, 2001) . trations of the drug (Strange, 2001) . These data still do not explain the wellThese data still do not explain the welldocumented discrepancy between the rapid documented discrepancy between the rapid D D 2 2 receptor blockade induced by antireceptor blockade induced by antipsychotic drugs and the gradual remission psychotic drugs and the gradual remission of psychotic symptoms over several days of psychotic symptoms over several days or weeks. This delay could result from or weeks. This delay could result from longer-term effects of antipsychotic drugs longer-term effects of antipsychotic drugs on brain plasticity, including (for example) on brain plasticity, including ( The above suggests that a reasonable goal The above suggests that a reasonable goal for effective, less-toxic treatment of schizofor effective, less-toxic treatment of schizophrenia is the regionally sensitive stabilisaphrenia is the regionally sensitive stabilisation of dopamine function, and not the tion of dopamine function, and not the 'blunderbuss' dopaminergic paralysis in-'blunderbuss' dopaminergic paralysis induced by classical antipsychotic drugs. This duced by classical antipsychotic drugs. This selective targeting could come about by selective targeting could come about by exploiting behaviour intrinsic to comexploiting behaviour intrinsic to compounds with low D pounds with low D 2 2 affinity, by designing affinity, by designing compounds selective for dopamine receptor compounds selective for dopamine receptor subtypes found at greater densities in subtypes found at greater densities in limbic or cortical regions (for example D limbic or cortical regions (for example D 3 3 receptors), or by modulating dopamine receptors), or by modulating dopamine release through action at alternative sysrelease through action at alternative systems (novel candidates include serotonin, tems (novel candidates include serotonin, sigma and glutamate receptor sites). Such sigma and glutamate receptor sites). Such ideas are certainly relevant to current therideas are certainly relevant to current therapeutics and future drug development. apeutics and future drug development. Novel agents with specific action at presyNovel agents with specific action at presynaptic D naptic D 3 3 autoreceptors controlling central autoreceptors controlling central dopamine release may offer more physiodopamine release may offer more physiological modulation of dopamine than conlogical modulation of dopamine than conventional antagonists (Reavill ventional antagonists (Reavill et al et al, 2000; , 2000; Strange, 2001) . It is apparent that as the Strange, 2001). It is apparent that as the neurochemical pathology of schizophrenia neurochemical pathology of schizophrenia is not fully understood, and as many is not fully understood, and as many patients are only partially responsive or patients are only partially responsive or are insensitive to dopaminergic antagonare insensitive to dopaminergic antagonism, many non-dopaminergic sites (espeism, many non-dopaminergic sites (especially those mediated by glutamate and cially those mediated by glutamate and serotonin) remain potent targets for future serotonin) remain potent targets for future drug discovery. The availability of highdrug discovery. The availability of highand low-affinity D and low-affinity D 2 2 /D /D 3 3 receptor antagonist receptor antagonist antipsychotic drugs offers clinicians much antipsychotic drugs offers clinicians much choice, and the above data provide a choice, and the above data provide a rational evidence base for prescribing, rational evidence base for prescribing, 2 7 3 2 7 3 
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